Activist 13D/13G Filings - Caligan Partners LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-03-06
7:30 pm
Purchase		13DANIKA THERAPEUTICS INC
ANIK		Caligan Partners LP1,423,493
9.7%		342,133increase
(+31.64%)		View
2024-01-08
5:00 pm
Sale		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP7,042,413
2.4%		-755,041decrease
(-9.68%)		View
2023-12-14
4:40 pm
Purchase		13DLIQUIDIA CORPORATION COM
LQDA		Caligan Partners LP10,360,945
15.3%		3,193,282increase
(+44.55%)		View
2023-09-11
06:01 am
Purchase		13DANIKA THERAPEUTICS INC
ANIK		Caligan Partners LP1,081,360
7.4%		179,274increase
(+19.87%)		View
2023-08-17
08:00 am
Purchase		13DANIKA THERAPEUTICS INC
ANIK		Caligan Partners LP902,086
6.2%		902,086increase
(New Position)		View
2023-08-03
4:30 pm
Sale		13DALIMERA SCIENCES INC
ALIM		Caligan Partners LP17,635,154
33.1%		-915,040,279,903decrease
(-100.00%)		View
2023-07-03
5:17 pm
Sale		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP7,797,454
9.9%		-779,345decrease
(-9.09%)		View
2023-06-02
5:05 pm
Purchase		13DEXELIXIS INC
EXEL		Caligan Partners LP910,730
0.28%		60,730increase
(+7.14%)		View
2023-05-18
5:24 pm
Purchase		13DALIMERA SCIENCES INC
ALIM		Caligan Partners LP915,057,915,057
9.99%		915,057,190,341increase
(+126264245.63%)		View
2023-03-28
5:00 pm
Purchase		13DALIMERA SCIENCES INC
ALIM		Caligan Partners LP724,716
9.99%		313,189increase
(+76.10%)		View
2023-03-27
5:20 pm
Unchanged		13DEXELIXIS INC
EXEL		Caligan Partners LP850,000
0.26%		0
(Unchanged)		View
2023-03-20
5:00 pm
Purchase		13DEXELIXIS INC
EXEL		Caligan Partners LP850,000
0.26%		850,000increase
(New Position)		View
2022-12-30
5:10 pm
Sale		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP8,576,799
10.8%		-2,868,037decrease
(-25.06%)		View
2022-12-09
5:00 pm
Sale		13DADMA BIOLOGICS INC
ADMA		Caligan Partners LP10,264,311
4.6%		-628,926decrease
(-5.77%)		View
2022-08-05
11:13 am
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP11,444,836
14.8%		1,021,648increase
(+9.80%)		View
2022-06-07
10:31 am
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP10,423,188
13.5%		938,350increase
(+9.89%)		View
2022-05-25
5:18 pm
Purchase		13DALIMERA SCIENCES INC
ALIM		Caligan Partners LP411,527
5.9%		411,527increase
(New Position)		View
2022-05-03
12:40 pm
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP9,484,838
12.3%		1,104,573increase
(+13.18%)		View
2022-03-29
5:14 pm
Unchanged		13DSTANDARD BIOTOOLS INC.
LAB		Caligan Partners LP8,380,265
10.9%		0
(Unchanged)		View
2022-02-04
08:30 am
Purchase		13DADMA BIOLOGICS INC
ADMA		Caligan Partners LP10,893,237
5.6%		10,893,237increase
(New Position)		View
Goto 0, 1, Next